RT @doctorRBC: Congenital malformations after intra-uterine exposure to non-TNFi when compared to certolizumab showed ve
Tweet Content
Congenital malformations after intra-uterine exposure to non-TNFi when compared to certolizumab showed vedolizumab and belimumab were associated with higher CMs. Vedolizumab showed specific CM pattern (corpus collosum agenesis).
@RheumNow #EULAR2022 ABST#OP0129 https://t.co/wgRlm9QLgW
Show on Archive Page
On
Display in Search Results
On
PDQ
Off